SPRAVATO® Recommendation Form
Thank you for taking the time to support your patients continued care for their treatment-resistant depression. While we don’t require any additional info, as we will be careful in conducting a thorough eval on patients upon referral, if you feel that you have any additional information that might be instrumental in ensuring an optimal continuity of care, please feel free to enter it below.
SPRAVATO® is contraindicated in patients with:
Aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial and peripheral arterial vessels) or arteriovenous malformation.
History of intracerebral hemorrhage.
Hypersensitivity to esketamine, ketamine, or any of the excipients.
For more information about SPRAVATO®, see our page on Depression Treatment.